Cushing's Syndrome Enrolling by Invitation Phase 2 Trials for Relacorilant (DB14976)

Also known as: Cushing Syndrome / Cushing’s syndrome / Cushings syndrome / Syndrome Cushing's

IndicationStatusPhase
DBCOND0028130 (Cushing's Syndrome)Enrolling by Invitation2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03604198Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing SyndromeTreatment